Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference

<p>SAN CARLOS, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the 2023 Wells Fargo Healthcare Conference: 2023 Wells Fargo Healthcare ConferenceFireside Chat: [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/iovance-biotherapeutics-to-present-at-2023-wells-fargo-healthcare-conference/">Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>